top of page

Metformin Hydrochloride Recall

Updated: Mar 29, 2021

Indian pharmaceutical company Marksans Pharma Limited is recalling metformin hydrochloride extended-release tablets because their levels of NDMA (cancer-causing contaminant) were higher than the acceptable daily intake limit of 96 nanograms per day, according to a recall published this week by the US Food and Drug Administration (FDA).

4 views0 comments


bottom of page